​​​
  1. What’s behind compliance glitches at Indian pharma

What’s behind compliance glitches at Indian pharma

Coordinated efforts by the USFDA, UKMHRA and WHO-GMP have uncovered several instances of non-compliance at Indian drug companies.

By: | Updated: August 12, 2016 1:21 PM

Coordinated efforts by the USFDA, UKMHRA and WHO-GMP have uncovered several instances of non-compliance at Indian drug companies. In the last two years, import ban orders have been issued by USFDA and Health Canada to over 25 Indian API and formulations, forcing companies to relook at their compliance management processes. Here are the findings of a survey to understand the perception of Indian pharma when it comes to managing challenges of regulatory non-compliance, internal controls and drug production standards.

For Updates Check Company News; follow us on Facebook and Twitter

 

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Go to Top